ELEV
|Elevation Oncology Inc
NASDAQ
USD 0.31
-0.00|-0.35%
Current Price
USD 0.31
Change
USD -0.00 (-0.35%)
P/E Ratio
Dividend Yield
Market Cap
17.92M
Volume
303,406
Open
USD 0.29
Previous Close
USD 0.31
52-Week High
USD 4.33
52-Week Low
USD 0.22
About Elevation Oncology Inc
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. It's lead candidate is EO-3021, an antibody-drug conjugate (ADC) comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload that is in Phase 1 clinical trial as a mon...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Joseph J. Ferra Jr.
Employees:34
Headquarters:Boston, USA
Website:elevationoncology.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions